In recent days, hebei province, hebei province, under the guidance of a team of experts on bone wounds and professor chen wei-jin, third hospital, beijing medical universityMidwest medical unionThe microbone injury unit in the osteoporosis section of the hospital was successfully administered with a bone fracture combined with medical artery inoculation, and the patient recovered from surgery. The successful landing of this front-line technology marked a new breakthrough in the level of treatment provided by the central west medical complex in quyuzhou, hebei province, in the form of a combination of broken bones, and a new, better-quality and microbone treatment programme for bone-dead patients in the region。
At present, the central west medical complex in fuzhou, hebei province, is taking advantage of the three national projects of china-china and west china-west medical services to promote a comprehensive strategy for the development of chinese medical excellence. As the hospital's core unit, the osteoporosis unit focuses on the integration of western and central medicine and actively pursues the high-quality medical resources of kyouta. In coordination with the leadership of the college, the unit has worked with the team of professor chen wei-hsiung, the third-affiliated hospital of the beijing medical university, to develop a long-term strategy for clinical research and technical upgrading and discipline development of the section with the help of top specialist resources。
Professor chen wei-tung is a national bone injury specialist, leader of the discipline at the centre for osteoporosis of the third hospital of the beijing medical university, director of the institute of osteoporosis of the beijing medical university, director of the centre for engineering research of the ministry of education, “intelligence in the treatment of bone injuries and physical rehabilitation of the chinese medical university”, a national candidate for the engineering of millions of talent in the new century, an expert on special allowances of the state council, and a young expert in the outstanding contribution of the national health commission. There is considerable experience in the use of the combination of chinese and western medicine for the treatment of multiple types of bone-related disorders, in particular bone death, osteoporosis, etc。
With regard to academic and scientific research, professor chen has led the development of 11 sectoral guidelines and diagnostic standards for knee arthritis, femur necrosis, and 22 national-level topics such as major national-level special projects and priority projects; over 300 papers have been published, of which more than 40 have been published by sci. The drug artery intervention treatment technology for this landing is the core result of several years of clinical research conducted by the team of professor chen wei-kung, which has been certified by a large number of clinical cases and has stabilized the treatment, while the team led the development of the "bone dead orchestra"InterventionThe chinese expert consensus laid down authoritative standards for the clinical normative application of the technology。
With a view to effectively addressing the regional challenges of patient access and introducing forward-looking treatment techniques, on 10 may 2026, the team of prof. Chen wei-chang was invited to the midwest medical union hospital in fuzhou, hebei province, to work with the hospital's vascular intervention team to successfully implement an arterial intervention treatment for a bone-infested patient. The patient's pain was reduced the day after the surgery, and the hip function was improved。
Prof. Chen wei-tung described the wide range of drug artery injection therapy techniques that can cover non-traumatized bone-mortality patients in different stages. The effect of early bone failure is to promote bone repair and protection, to mitigate symptoms of mid-term and end-stage bone failure, to delay the replacement of joints for time, and to mitigate hip pain and improve joint function for patients who unconditionally replace joints for multiple causes of end-stage bone death。
The drug artery inoculation treatment technique is widely adapted to cover patients with non-traumatological bone failure in different stages. The effect of early bone failure is to promote bone repair and protection, to mitigate symptoms of mid-term and end-stage bone failure, to delay the replacement of joints for time, and to mitigate hip pain and improve joint function for patients who unconditionally replace joints for multiple causes of end-stage bone death。
The death of a bone is a serious disabling disease, with an accumulation of 8. 12 million non-traumatized bone deaths nationwide, an estimated 1. 02 per cent for men, a very high rate of collapse of uninvolved bone deaths, a collapse of about 80 per cent of untreated cases within one to four years, and a two-year interval between the onset of a collapse and the replacement of 87 per cent of cases. Secretary zhao jianyong pointed out that avoiding the collapse of a bone and becoming the key to the treatment of a bone incubation, using the medical resources of kyojin to take advantage of the medical features of the midwest medical complex in fuzhou, hebei province, introducing new technologies, combining medical treatment in china and west and improving the effectiveness of treatment for bone deaths, and the microbreeding section of the midwest medical hospital in fuzhou, hebe province, will study systematically the consensus of chinese experts on the treatment of bone increasure interventions, introduce drug artery injection techniques to treat bone defects in the unit, and actively work with beijing experts to ensure the health of the west and central western medical department for the benefit of patients。
At present, the midwest medical complex in fuzhou, hebei province, has entered into a strategic collaboration with the team of professor chen wei-cheng, who regularly visit the hospital to supervise the microbone injury unit on a monthly basis, and to conduct an appointment at an osteoporal specialist clinic。
